Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70)
Timothy M. E. Davis, Rury R. Holman(Chinese University of Hong Kong), Alex Wright(NIHR Surgical Reconstruction and Microbiology Research Centre), Irene Stratton(University of Oxford), C A Cull(Churchill Hospital), Emanuele Bosi(Vita-Salute San Raffaele University), Z Mehta(Cleveland Clinic), G. F. Bottazzo(Bambino Gesù Children's Hospital)
Cited by 116
Related Papers
Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range
|Diabetes Care|2019|3.8k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
International Consensus on Use of Continuous Glucose Monitoring
|Diabetes Care|2017|2k